Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Shilatifard Receives Walder Research Award
Campus News

Shilatifard Receives Walder Research Award

By Marla PaulJun 28, 2016
Share
Facebook Twitter Email
Ali_Shilatifard
Ali Shilatifard, PhD, has been named the 15th recipient of the Martin E. and Gertrude G. Walder Award for Research Excellence, given annually by the provost, which recognizes excellence in research at Northwestern University.

Ali Shilatifard, PhD, Robert Francis Furchgott Professor and chair of Biochemistry and Molecular Genetics, has been named the 15th recipient of the Martin E. and Gertrude G. Walder Award for Research Excellence.

This award, established in 2002 by Dr. Joseph A. Walder and given annually by the provost, recognizes excellence in research at Northwestern. Walder earned his doctoral and medical degrees from Northwestern and then founded IDT, a company that supplies synthetic DNA for research and clinical applications. A complete list of award recipients can be found on Northwestern University’s Office of the Provost website.

Shilatifard, who joined Northwestern in 2014, is a biochemist and molecular biologist and a respected expert in the field of transcription and epigenetics, specifically as it relates to cancer biology. He has an immense interest in understanding the intricate molecular mechanisms the regulate gene expression and activate or suppress a particular gene’s trait, especially how both inherited and environmental factors, or epigenetics, play a role in the development of human disease, including cancer.

As a Jane Coffin Childs postdoctoral fellow at the Oklahoma Medical Research Foundation, Shilatifard made a seminal contribution to the field of leukemia biology by identifying the first function of any of the MLL translocation partners, which is when a section of one chromosome changes place with that of another chromosome, creating a mutation. In the 20 years that followed, he has dedicated his career to pursuing these important questions that directly relate to improving outcomes in individuals’ prognoses when diagnosed with cancer.

Shilatifard’s studies have made significant inroads to understanding the cause of childhood leukemia. Research from his laboratory is leading to the development of promising, target-specific drugs for childhood leukemia and other forms of cancers. The epigenetic inhibitors developed in Shilatifard’s laboratory are being tested for the treatment of childhood leukemia, brain cancer and other solid tumors.

Shilatifard, who is a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, has been recognized by the Leukemia and Lymphoma Society as the recipient of the Sword of the American Cancer Society and received the AMGEN Award from the American Society for Biochemistry and Molecular Biology. He has been funded through three major grants from the National Institutes of Health and the National Cancer Institute.

Recently, Shilatifard was selected as an inaugural recipient of the Outstanding Investigator Award from the National Cancer Institute. He serves as a senior editor for the journal Science, a deputy editor for Science Advances and editor for Molecular and Cellular Biology. He also serves on the scientific advisory boards of Genentech, the Max Planck Society and Cell Signaling Technology.

Awards Biochemistry Epigenetics Faculty
Share. Facebook Twitter Email

Related Posts

Distinguished Implementation Scientist to Lead Medical Social Sciences

Jun 14, 2022

Northwestern Faculty Elected to Society for Clinical Trials Board

Jun 8, 2022

Remembering John Csernansky, MD

Jun 6, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.